Allmed Solutions Ltd (TLV:ALMD)

Allmed Solutions Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	-	-	-	-	5.55
Revenue Growth (YoY)	-	-	-	-	-42.95%
Cost of Revenue	-	-	-	-	2.46
Gross Profit	-	-	-	-	3.08
Selling, General & Admin	5	5.17	5.43	6.96	6.66
Research & Development	8.02	5.9	5.24	5.33	5.6
Other Operating Expenses	-	-	0.19	0.11	-0.22
Operating Expenses	13.02	11.07	10.85	12.41	12.04
Operating Income	-13.02	-11.07	-10.85	-12.41	-8.96
Interest Expense	-0.06	-0.06	-0.08	-0.05	-0.1
Interest & Investment Income	1.44	2.12	1.75	0.02	0
Earnings From Equity Investments	-	-	-1.76	-2.71	-1.14
Currency Exchange Gain (Loss)	-2.5	0.26	0.46	2.05	-1.01
Other Non Operating Income (Expenses)	0.01	-	4.41	0.95	-1.35
EBT Excluding Unusual Items	-14.12	-8.75	-6.08	-12.15	-12.54
Gain (Loss) on Sale of Investments	-	-	-4.94	-	-0.22
Gain (Loss) on Sale of Assets	-	-	12.61	-	18.85
Other Unusual Items	-	-	-0.17	0.01	-3.39
Pretax Income	-14.12	-8.75	1.42	-12.14	2.7
Earnings From Continuing Operations	-14.12	-8.75	1.42	-12.14	2.7
Minority Interest in Earnings	-	-	-	-	0.11
Net Income	-14.12	-8.75	1.42	-12.14	2.81
Net Income to Common	-14.12	-8.75	1.42	-12.14	2.81
Shares Outstanding (Basic)	96	99	108	88	81
Shares Outstanding (Diluted)	96	99	108	88	81
Shares Change (YoY)	-3.09%	-8.33%	23.15%	8.97%	0.37%
EPS (Basic)	-0.15	-0.09	0.01	-0.14	0.03
EPS (Diluted)	-0.15	-0.09	0.01	-0.14	0.03
Free Cash Flow	-12.13	-8.14	7.02	-10.65	-5.52
Free Cash Flow Per Share	-0.13	-0.08	0.07	-0.12	-0.07
Gross Margin	-	-	-	-	55.60%
Operating Margin	-	-	-	-	-161.55%
Profit Margin	-	-	-	-	50.64%
Free Cash Flow Margin	-	-	-	-	-99.57%
EBITDA	-12.84	-10.86	-10.38	-11.86	-7.9
EBITDA Margin	-	-	-	-	-142.40%
D&A For EBITDA	0.18	0.21	0.48	0.55	1.06
EBIT	-13.02	-11.07	-10.85	-12.41	-8.96
EBIT Margin	-	-	-	-	-161.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.